emtricitabine + tenofovir alafenamide fumarate · Medicine question

What minimum age and body weight are specified for treating HIV-1 with Emtricitabine/Tenofovir Alafenamide Gilead?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Emtricitabine/Tenofovir Alafenamide Gilead is indicated with other antiretroviral agents for HIV-1 treatment in adults and adolescents aged at least 12 years and weighing at least 35 kg.

Sources for this answer

Emtricitabine/Tenofovir Alafenamide Gilead 200 mg/10 mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 25Document updated 22 October 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about emtricitabine + tenofovir alafenamide fumarate